Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Rapid City, S.D.-based Regional Health earned the Ascend Peak Performance Award for exceptional clinical and supply chain performance.
The Indiana Blood Center reached a critically low supply of O-negative blood on Monday, causing the center to send out an urgent call for donations, reported the Tribune Star.
A new study shows supply chain executives demonstrate higher levels of psychopathic tendencies than any other role in the business world, reports the AustralianFinancial Review.
Lake Forest, Ill.-based Horizon Pharma will reportedly buy La Jolla, Calif.-based Raptor Pharmaceutical for $800 million, according to Reuters.
Veniti, the developer of a patented venous stent system, has secured $25 million in funding from Boston Scientific Corp. The company will use the investment to complete a trial and regulatory filing for its stent system as well as grow…
San Diego-based Obalon Therapeutics earned Food and Drug Administration approval for its Obalon Balloon System, a nonsurgical weight loss device for patients who failed to lose weight through diet and exercise.
GlaxoSmithKline will sell its anesthetic drug business to South Africa-based Aspen Pharmacare for up to $372 million.
Israel-based Teva Pharmaceuticals seeks to earn Food and Drug Administration approval for its generic version of Mylan's EpiPen by late 2017 or early 2018.
The Food and Drug Administration recently approved India-based Glenmark Pharmaceutical's lidocaine ointment.
The high price of EpiPens introduced a nationwide discussion on Mylan's pricing practices and the overall state of the drug industry. However, not all parts of the discussion have been accurate.